Analysis

Higher ivermectin dose, longer duration still futile for COVID, trial finds CIDRAP

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.

Study shows brain changes after COVID-19 infection, even in mild cases - UPI.com People who are experiencing anxiety and depression months after a mild case of COVID-19 may have changes affecting the structure and function of their brains, Brazilian researchers report. UPI

...

"Our findings are concerning, as even people with a mild case of COVID-19 are showing changes in their brains months later. More studies are needed to hopefully identify treatments to prevent any long-term effects on people's quality of life," she added.

Could old coronavirus variants ever come back? The virus is evolving through a "continual game of cat and mouse between the virus and our immune systems," an epidemiologist explained. YahooNews

What happened to the variants that once wreaked havoc? “For all intents and purposes, we can consider them gone,” said David Dowdy, an epidemiology professor at Johns Hopkins Bloomberg School of Public Health.